Ono Pharmaceutical and Kawasaki Heavy Industries Report Strong Earnings Growth

Tokyo, Tuesday, 11 November 2025.
Ono Pharmaceutical and Kawasaki Heavy Industries have reported notable earnings growth for Q3 2025, driven by cancer drug sales and aerospace demand, reflecting Japan’s industrial resilience and innovation.